secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0000950170-24-065636
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron submits PAS to FDA for ZYNRELEF Vial Access Needle to simplify preparation
--------------------------------------------------------------------------------

- PAS seeks FDA approval to replace current vented vial spike with new Vial Access Needle (VAN).
- VAN reduces product withdrawal time from up to 3 minutes to 20-45 seconds, simplifying aseptic preparation.
- Heron expects FDA review action date within 4-6 months; decision pending.
- ZYNRELEF is already approved for postoperative pain; VAN addresses healthcare provider feedback.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017024065636/0000950170-24-065636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017024065636/hrtx-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-065636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer